SCHEMBL7369916

SCHEMBL7369916

O=c1oc2ccccc2nc1-c1cc(O)c(O)c([N+](=O)[O-])c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHBP P24387 1/20 0.46
CRHR2 Q13324 1/20 0.46
MMP2 P08253 1/20 0.42
MMP9 P14780 1/20 0.42
MMP8 P22894 1/20 0.42
MMP13 P45452 1/20 0.42
MAPT P10636 7/20 0.41
KMT2A Q03164 6/20 0.41
MEN1 O00255 5/20 0.41
ALDH1A1 P00352 4/20 0.41
HPGD P15428 4/20 0.41
LMNA P02545 3/20 0.41
TDP1 Q9NUW8 3/20 0.41
RECQL P46063 2/20 0.41
HSP90AA1 P07900 1/20 0.41
XBP1 P17861 1/20 0.41
HKDC1 Q2TB90 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HTT P42858 2/20 0.41
MAPK1 P28482 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7372386 0.86 MAPT (0.47) MMP2MMP9MMP8MMP13MAPT
SCHEMBL7373423 0.85 MMP2 (0.47) CRHBPCRHR2MMP2MMP9MMP8
SCHEMBL7373907 0.85 GAA (0.40) CRHBPCRHR2MAPTKMT2AMEN1
SCHEMBL7373195 0.83 ERN1 (0.41) CRHBPCRHR2ALDH1A1HPGDLMNA
SCHEMBL7373198 0.81 RAB9A (0.37) CRHBPCRHR2MAPTKMT2AMEN1
SCHEMBL7370455 0.81 ALDH1A1 (0.38) CRHBPCRHR2MAPTKMT2AMEN1
SCHEMBL7370121 0.77 MAPT (0.43) MMP2MMP9MMP8MMP13MAPT
SCHEMBL7366603 0.76 NPC1 (0.53) CRHBPCRHR2MMP2MMP9MMP8
SCHEMBL7372667 0.76 TTR (0.41) CRHBPCRHR2MAPTKMT2AMEN1
SCHEMBL7371972 0.74 ALDH1A1 (0.55) CRHBPCRHR2MAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5705703-A ENZYME INHIBITORS OF TRANSFERASES HOFFMANN-LA ROCHE INC. (US) 1998-01-06 US disclosed
US-5633371-A ENZYME INHIBITORS; TREATMENT OF DEPRESSION AND PARKINSON*S DISEASE HOFFMANN-LA ROCHE INC. (US) 1997-05-27 US disclosed
US-5476875-A Catechol derivatives HOFFMAN-LA ROCHE INC. (US) 1995-12-19 US disclosed
US-5389653-A Inhibitors of the enzyme catechol-O-methyltransferase; useful as co-medication in treatment of Parkinson's disease HOFFMAN-LA ROCHE INC. (US) 1995-02-14 US disclosed
US-5236952-A Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa HOFFMANN-LA ROCHE INC. (US) 1993-08-17 US disclosed
EP-0237929-B1 3,5-DISUBSTITUTED PYROCATECHOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1993-06-02 EP disclosed
EP-0237929-A1 3,5-Disubstituted pyrocatechol derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-09-23 EP disclosed